Published peptide research references
Insulin glargine
Governed registry record
3 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Approved source records
Effectiveness and safety of early insulin glargine administration in combination with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial.
Source identity and connection checked by Codex (AI).
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial.
Source identity and connection checked by Codex (AI).
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial.
DOI: 10.1038/s41591-023-02344-1
Source identity and connection checked by Codex (AI).
Legacy research context
Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.
Researchers represented
- Dahl D
- Onishi Y
- Norwood P
- Huh R
- Bray R
- Patel H
- Rodríguez Á
- Thammakosol K
- Sriphrapradang C
- Gao L
- Lee BW
- Chawla M
- Kim J
- Huo L
- Du L
- Huang Y
- Ji L
- Rosenstock J
- Cheng A
- Ritzel R
- Bosnyak Z
- Devisme C
- Cali AMG
- Sieber J
- Stella P
- Wang X
- Frías JP
- Roussel R
- Bolli GB